Bridgeway Capital Management’s PMV Pharmaceuticals PMVP Stock Holding History

Bridgeway Capital Management’s Portfolio PMVP Stock Details PMVP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$532K	Hold	428,853	–	–	0.01%	815
2025 Q4	$536K	Buy	428,853 +108,200	+34%	+$145K	0.01%	810
2025 Q3	$449K	Buy	320,653 +171,853	+115%	+$238K	0.01%	826
2025 Q2	$158K	Hold	148,800	–	–	﹤0.01%	1008
2025 Q1	$162K	Sell	148,800 -53,300	-26%	-$72.4K	﹤0.01%	960
2024 Q4	$305K	Buy	202,100 +62,200	+44%	+$98.5K	0.01%	919
2024 Q3	$208K	Hold	139,900	–	–	﹤0.01%	1057
2024 Q2	$227K	Buy	139,900 +64,900	+87%	+$117K	0.01%	1029
2024 Q1	$128K	Sell	75,000 -119,900	-62%	-$224K	﹤0.01%	1180
2023 Q4	$604K	Buy	194,900 +99,900	+105%	+$264K	0.01%	895
2023 Q3	$583K	Hold	95,000	–	–	0.01%	840
2023 Q2	$595K	Buy	+95,000	New	+$498K	0.01%	858

Other funds holding PMVP

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Bridgeway Capital Management's PMVP Position: Q1 2026 in Review

Bridgeway Capital Management held its PMV Pharmaceuticals (PMVP) position steady in Q1 2026 at 428,853 shares worth $532K. The position accounts for 0.01% of the portfolio, ranked #815.

Bridgeway Capital Management first reported a position in PMVP in Q2 2023 and has held it in 12 quarters since. The position peaked at $604K in Q4 2023. 69 funds tracked by Wall St. Rank hold PMVP as of Q1 2026.

Bridgeway Capital Management held 428,853 shares of PMV Pharmaceuticals worth $532K as of Q1 2026.
Bridgeway Capital Management left its PMV Pharmaceuticals share count unchanged in Q1 2026.
PMV Pharmaceuticals made up 0.01% of Bridgeway Capital Management's portfolio in Q1 2026, its #815 holding.
Bridgeway Capital Management first reported a position in PMV Pharmaceuticals in Q2 2023 and has held it in 12 quarters since.
Bridgeway Capital Management's PMV Pharmaceuticals position peaked at $604K in Q4 2023.
69 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2026.

Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.